ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 240 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2023. The put-call ratio across all filers is 1.15 and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 1,060,613 | $48,926,107 | 0.01% |
| STATE STREET CORP | 2,465,450 | $113,731,209 | 0.01% |
| TEACHER RETIREMENT SYSTEM OF TEXAS | 19,049 | $879 | 0.01% |
| GILDER GAGNON HOWE & CO LLC | 9,648 | $445,062 | 0.01% |
| Bank of New York Mellon Corp | 642,986 | $29,660,928 | 0.01% |
| AdvisorNet Financial, Inc | 1,500 | $69,195 | 0.01% |
| Invesco Ltd. | 377,349 | $17,407,109 | 0.01% |
| AMALGAMATED BANK | 14,687 | $678 | 0.01% |
| Swiss National Bank | 152,852 | $7,051,063 | 0.01% |
| RHUMBLINE ADVISERS | 93,037 | $4,291,796 | 0.01% |
| Verition Fund Management LLC | 7,507 | $346,298 | 0.01% |
| CAPTRUST FINANCIAL ADVISORS | 24,840 | $1,145,869 | 0.01% |
| Covestor Ltd | 152 | $7 | 0.01% |
| Maryland State Retirement & Pension System | 4,688 | $216,257 | 0.01% |
| VIRGINIA RETIREMENT SYSTEMS ET AL | 10,800 | $498,204 | 0.01% |
| SEI INVESTMENTS CO | 65,754 | $3,033,223 | 0.01% |
| OPPENHEIMER ASSET MANAGEMENT INC. | 7,091 | $327,108 | 0.01% |
| QUADRANT CAPITAL GROUP LLC | 1,167 | $53,834 | 0.01% |
| MARTINGALE ASSET MANAGEMENT L P | 5,406 | $249,379 | 0.01% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 377,238 | $17,401,989 | 0.01% |
External links
This page lists ULTRAGENYX PHARMACEUTICAL IN's shareholders in Q2 2023. To view ULTRAGENYX PHARMACEUTICAL IN's shareholder history, click here.